Eyebright Cert.Organic

Description: Dried Aerial Parts of  Eyebright Herb. 

Status: Certified Organic

Botanical Name: Euphrasia Officinalis 

Common Names: Eyebright 

Parts Used: The Aerial Parts

Country of Origin: Germany

Traditional Use: Eyebright has been used in Europe for centuries as a traditional medicine for treatment of various diseases. Decoctions and infusions of flowering aerial parts are used against dry cough, hoarseness, symptomatic treatment of cold, earache, and headache, hay fever, purulent skin lesion, or catarrhal diseases of the intestinal tract, but especially as eyewash to treat and prevent eye disorders such as conjunctivitis, blepharitis, eye fatigue, purulent ocular inflammation, and sties.

Evidence-based Studies: Recent studies indicate that Eyebright contains compounds of particular benefit to the eyes.The therapeutic effect of Eyebright can be attributed mainly to its antioxidant, anti-inflammatory, and antimicrobial activity. Eyebright tightens the mucous membranes of the eye and relieves the inflammation of conjunctivitis and blepharitis. Its ability to counter mucus means that eyebright is often used for infectious and allergic conditions affecting the eyes, middle ear, sinuses, and nasal passages.

Recommendations: Considering the benefits of this herb, drink the tea or use the extract. For best results, we blend different extracts with similar properties and complementary therapeutic action, as in the popular and highly praised by generations of customers Vision Drops and Sinus Drops. Please contact the pharmacy for additional information. 

References:

European Medicines Agency. Assessment Report on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, Herba. London, UK: European Medicines Agency; 2010. (A Report of Committee on Herbal Medicinal Products). http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2011/01/WC500100385.pdf.

Darshan S., Doreswamy R. Patented antiinflammatory plant drug development from traditional medicine. Phytotherapy Research. 2004;18(5):343–357. doi: 10.1002/ptr.1475. [PubMed]